Cinqair (reslizumab)
Billing
Code: J2786
Description: Injection, reslizumab, 1mg
Unit: 1 mg
Payment: $10.301
Pay quarter: Q4 2023
Dosage and Frequency
Severe asthma
• 3mg/kg IV every 4 weeks
• 3mg/kg IV every 4 weeks
Calculate drug reimbursement
Total Reimbursement:
$2,163.21(ASP: $2,040.76, Margin: $122.45)
Code:
J2786# Units to bill:
210Prior Authorization
Prior auth criteria for Cinqair may include but is not limited to:
1. Diagnosis of asthma or COPD
2. Documented inadequate response to an appropriate trial of at least 2 maintenance medications
3. Age 18 years or older
4. FEV1/FVC < 70% or FEV1 < 80% predicted
5. Patient must not be pregnant or breastfeeding
6. Patient must not have been previously treated with Cinqair
7. Patient must not have any contraindications to Cinqair
8. Patient must not have any active infections or malignancies
Insurance prior auth guidelines:
Billable NDCs
59310-0610-31
CINQAIR (IVAX LABS INC.)
100 MG
Resources